Yogi Care Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-11-2024
- Paid Up Capital ₹ 0.10 M
as on 02-11-2024
- Company Age 3 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.02 Cr
as on 02-11-2024
- Revenue %
(FY 2023)
- Profit -2869.48%
(FY 2023)
- Ebitda -1404.37%
(FY 2023)
- Net Worth -8468.52%
(FY 2023)
- Total Assets 11703.69%
(FY 2023)
About Yogi Care Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.02 Cr.
Maheshkumar Patodia, Prakash Kathiria, and Dipak Kathiria serve as directors at the Company.
- CIN/LLPIN
U51909GJ2021PTC127979
- Company No.
127979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Yogi Care Pharmaceutical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipak Kathiria  | Director | 14-Dec-2021 | Current |
| Maheshkumar Patodia | Director | 14-Dec-2021 | Current |
| Prakash Kathiria | Director | 14-Dec-2021 | Current |
Financial Performance of Yogi Care Pharmaceutical.
Yogi Care Pharmaceutical Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2869.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 8468.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yogi Care Pharmaceutical?
Unlock access to Yogi Care Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Yogi Life Care LlpActive 3 years 5 monthsMaheshkumar Patodia and Prakash Kathiria are mutual person
- Akshar International Private LimitedActive 2 years 9 months
Prakash Kathiria and Dipak Kathiria are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jun 2024 | ₹3.15 Cr | Open |
Others Creation Date: 21 Jun 2022 | ₹1.87 Cr | Open |
How Many Employees Work at Yogi Care Pharmaceutical?
Yogi Care Pharmaceutical has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yogi Care Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yogi Care Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
